85614-51-3 Usage
Chemical nature
Derivative of gamma-aminobutyric acid (GABA)
Medical use
Treatment of spasms, cramping, and tightness of muscles
Caused by conditions like multiple sclerosis, spinal cord injuries, and other spinal cord diseases
Mechanism of action
GABA receptor agonist
Activates and enhances the effects of GABA, an inhibitory neurotransmitter in the central nervous system
Resulting effects
Reduction in nerve cell activity in the brain and spinal cord
Leads to muscle relaxation and relief from muscle spasticity
Available forms
Oral and injectable
Side effects
Drowsiness, dizziness, and weakness (generally well-tolerated)
Check Digit Verification of cas no
The CAS Registry Mumber 85614-51-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,5,6,1 and 4 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 85614-51:
(7*8)+(6*5)+(5*6)+(4*1)+(3*4)+(2*5)+(1*1)=143
143 % 10 = 3
So 85614-51-3 is a valid CAS Registry Number.
InChI:InChI=1/C12H17NO2/c1-4-12(11(14)15,13(2)3)10-8-6-5-7-9-10/h5-9H,4H2,1-3H3,(H,14,15)
85614-51-3Relevant academic research and scientific papers
HEPATITIS C VIRUS INHIBITORS
-
Page/Page column 121, (2012/02/15)
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
HEPATITIS C VIRUS INHIBITORS
-
Page/Page column 131, (2010/12/26)
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
